Impact of gestrinone on the course of asymptomatic endometriosis.

Author: CookeI D, ThomasE J

Paper Details 
Original Abstract of the Article :
A new drug, gestrinone, was subjected to the first double blind, randomised placebo controlled trial of any treatment of endometriosis. The disease deteriorated in eight (47%) of the 17 patients prescribed placebo (95% confidence limits 23% and 71%) compared with none of the 18 patients prescribed g...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1136/bmj.294.6567.272

データ提供:米国国立医学図書館(NLM)

Gestrinone: A Promising Treatment for Endometriosis

Endometriosis, a condition where tissue similar to the uterine lining grows outside the uterus, can be a source of significant discomfort for women. This research investigates the effectiveness of gestrinone, a new drug, in treating asymptomatic endometriosis. The researchers conducted a double-blind, randomized, placebo-controlled trial to evaluate the impact of gestrinone on the progression of the disease.

Gestrinone Shows Promise in Endometriosis Treatment

The study found that gestrinone significantly improved the condition of endometriosis in patients, with a statistically significant difference in improvement compared to the placebo group. The results suggest that gestrinone could be a valuable treatment option for endometriosis, potentially offering relief from symptoms and preventing further deterioration of the disease.

Understanding and Managing Endometriosis

This study provides valuable insights into the potential of gestrinone as a treatment for endometriosis. The results highlight the importance of early diagnosis and intervention, especially considering that endometriosis can deteriorate in a significant proportion of patients. This knowledge can empower individuals to seek medical attention and explore treatment options if they suspect they may have endometriosis.

Dr. Camel's Conclusion

Like a camel traversing a rocky terrain, the path to managing endometriosis can be challenging. This study offers a glimmer of hope, showcasing the potential of gestrinone as a valuable treatment option. The research emphasizes the importance of early detection and timely intervention to potentially mitigate the progression of the disease. By understanding the complexities of endometriosis and exploring various treatment approaches, we can help individuals navigate this condition and find relief from its symptoms.

Date :
  1. Date Completed 1987-04-08
  2. Date Revised 2019-05-01
Further Info :

Pubmed ID

3101839

DOI: Digital Object Identifier

10.1136/bmj.294.6567.272

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.